A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/426 (2006.01) A61P 11/00 (2006.01) A61P 17/00 (2006.01) A61P 27/00 (2006.01)
Patent
CA 2520957
The present invention provides a method for treating a vascular hyperpermeable disease (except macular edema), which method comprises administering to a patient in need thereof a vascular adhesion protein-1 (VAP-1) inhibitor in an amount sufficient to treat said patient for said disease. The agents are 2- acylamino thiazole compounds.
La présente invention a trait à un procédé pour le traitement d'une maladie vasculaire hyperperméable (à l'exception d'oedème maculaire), comprenant l'administration à un patient qui en a besoin d'un inhibiteur de protéine d'adhésion vasculaire (VAP-1) en une quantité suffisante pour traiter ledit patient de ladite maladie. Les agents sont des composés de 2-acylamino thiazole.
Inoue Takayuki
Nagashima Akira
Ohkubo Mitsuru
Ueno Ryuji
Yoshihara Kousei
Astellas Pharma Inc.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
R-Tech Ueno Ltd.
Sucampo Ag
LandOfFree
Method for treating vascular hyperpermeable disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating vascular hyperpermeable disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating vascular hyperpermeable disease will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1824786